In support of this, treatment of MCF-7 and MDA-MB-231 breast cancer cells using GPIbα antibodies, not only reduced platelet-tumour cell interactions, but also attenuated the adhesion of tumour cells to endothelial cells in vitro [49]. Here, GP1BA is linked to neoplasm.